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Objective: CA-125 protein is used as a marker in clinical practice for the diagnosis of endometriomas. The
aim of this study was to determine whether endometriomas are accompanied by an increased level of
urocortin, ghrelin, and leptin, as well as the increased parameters of blood cell count, ﬁbrinogen, and
CA-125.
Materials and methods: The study included 86 women aged 18e38 years who had been treated lapa-
roscopically for lesions in the adnexa with the characteristics of endometriomas and mature teratoma,
during the period September 2009 to November 2012. The statistical analysis was performed using the
nonparametric ManneWhitney U test and the Spearman rank correlation coefﬁcients (p  0.05).
Results: The medians were 105.31 pg/mL versus 120.84 pg/mL for urocortin, 7.16 pg/mL versus 9.13 pg/
mL for leptin and 584.33 pg/mL versus 657.82 pg/mL for ghrelin (p > 0.05), respectively. Analyzing the
parameters of blood cell count, statistically signiﬁcant differences were shown in the respective groups
for leucocyte level (5.35  109/L vs. 6.7  109/L; p ¼ 0.029), ﬁbrinogen level (3.12 mg% vs. 2.57 mg%;
p ¼ 0.001), and CA-125 (36.50 U/mL vs. 15.08 U/mL; p ¼ 0.001).
Conclusion: In conclusion, the prognostic values for CA-125, leukocytes, and ﬁbrinogen may prove a very
useful tool for the diagnosis of lesions in the adnexa of the type endometriomas.
Copyright © 2015, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
Endometriosis is an estrogen-dependent, chronic disease con-
sisting of the implantation and hyperplasia of the endometrium
outside the uterine cavity, with an immunological and inﬂamma-
tory origin that results in pelvic pain [1]. It manifests as peritoneal
grafts and adhesions, as well as endometriomas (in 17e44% of pa-
tients of reproductive age). Unfortunately, the medical history of a
patient as well as a gynecological examination does not lead to a
full diagnosis of endometriomas. The ovarian endometriomas can
only be detected by a transvaginal ultrasonography [2e4]. Nowa-
days, there is signiﬁcant interest in plasma markers in endometri-
osis together with the diagnosis of endometriomas. However,znan, Poland.
Chmaj-Wierzchowska).
bstetrics & Gynecology. Publisheddespite the large number of potential biochemical markers, only
the CA-125 protein is commonly used in everyday clinical practice.
The aim of this studywas to determinewhether endometriomas
were accompanied by an increased level of urocortin, ghrelin, and
leptin together with increased parameters of blood cell count and
ﬁbrinogen, CA-125.Material and methods
The study comprised 86 female patients, aged 18e38 years, who
were treated laparoscopically at the Obstetrics and Gynecology
Hospital of the Poznan University of Medical Sciences. The patients
were being treated for lesions in the adnexa (both endometriomas
and mature teratoma) from September 2009 until November 2012.
Nonehormone-dependent benign ovarian lesions with mature
teratoma were selected for the study. This approach avoids the
impact of estradiol on the level of chemokines in the blood serum.by Elsevier Taiwan LLC. All rights reserved.
Table 1
General characteristics of patients with lesions in the adnexa of the forms endo-
metriomas (Group E) and mature teratomas (Group T).
Group E Group T p
Average ± SD (median)
Age (y) 30.00 ± 4.60 (31) 27.03 ± 4.52 (26) 0.002*
Body weight (kg) 67.00 ± 13.00 (64) 64.70 ± 11.83 (64) 0.394
Height (cm) 170.70 ± 7.01 (170) 170.46 ± 6.07 (170) 0.395
Diameter of lesion
in right ovary (mm)
49.29 ± 14.91 48.64 ± 15.03 0.876
Diameter of lesion
in left ovary (mm)
48.13 ± 17.87 44.29 ± 10.92 0.474
*p < 0.05 by ManneWhitney test.
SD ¼ standard deviation.
Table 2
Comparison of urocortin, leptin, and ghrelin serum level in patients with endome-
triomas (Group E) and mature teratomas (Group T).
Determination Group Average SD Max. Min. Median P
Urocortin
(pg/mL)
E 252.37 348.77 1228.604 0.145 105.31 0.727
T 256.03 353.92 1227.27 1.03 120.84
Leptin
(pg/mL)
E 8.06 5.19 22.25 0.11 7.16 0.284
T 9.82 6.31 20.68 1.52 9.13
Ghrelin
(pg/mL)
E 606.78 261.18 1892.06 180.00 584.33 0.153
T 627.42 158.50 884.58 185.67 657.82
SD ¼ standard deviation.
Table 3
Spearman correlations test in the endometrioma group.
Urocortin
(pg/mL)
Leptin
(ng/mL)
Ghrelin
(pg/mL)
CA-125 (U/mL)
Urocortin (pg/mL) 0.113 0.121 0.221 R
0.475 0.487 0.164 P
Leptin (ng/mL) 0.118 0.064 R
0.483 0.670 P
Ghrelin (pg/mL) 0.073 R
0.666 P
Table 4
Spearman correlations test in the group of surgically treated mature teratomas.
Urocortin
(pg/mL)
Leptin
(ng/mL)
Ghrelin
(pg/mL)
CA-125 (U/mL)
Urocortin (pg/mL) 0.13 0.0153 0.066 R
0.439 0.938 0.702 P
Leptin (ng/mL) 0.261 0.216 R
0.186 0.205 P
Ghrelin (pg/mL) 0.195 R
0.329 P
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dependent benign ovarian lesions.
Selection of women for the study was based on the histopath-
ological examination. After examination, the patients were divided
into two study groups: Group E (endometriomas) comprised
women (n ¼ 48) with histopathologically conﬁrmed endome-
triomas without coexisting foci of peritoneal endometriosis; and
Group T (mature teratoma) comprised women (n ¼ 38) that un-
derwent laparoscopic surgery of ovarian tumors with mature
teratomas.
All patients met the following criteria: no obstetric history; no
accompanying diseases; intraoperative diagnosis of endometrioma
with no macroscopic peritoneal endometriosis; and/or ovarian
tumor of the mature teratoma form. No abnormalities in the blood
coagulation system were found in the preoperative examination.
The laparoscopy was performed during the ﬁrst stage of the men-
strual cycle in all patients. Cytokine levels after laparoscopic sur-
gery were not measured. The patients had no history of treatment
for infertility. The blood samples were collected on the admission
day, that is, a day before the procedure, in the morning, and in a
fasting state.
The level of the ﬁbrinogen, the blood cell counts, and the CA-125
level, were measured immediately in the hospital laboratory. Uro-
cortin, ghrelin, and leptin were determined in a blood sample after
it was centrifuged and frozen to 20C. The level of urocortin
(USCN, Wuhan, China), ghrelin (Millipore, Billerica, MA, USA) and
leptin (Millipore) in the blood serumwas determined with the use
of ELISA, a double determinant, to verify the measurement error.
The concentrations were determined using units of pg/mL for
average ± standard deviation and median. The minimum and the
maximumvalues were also speciﬁed. The level of these cytokines in
the blood sample as a diagnostic method of endometriomas has not
been previously mentioned in a scientiﬁc study.
The statistical analysis was performed with the nonparametric
ManneWhitney U test for urocortin, leptin, and ghrelin and com-
ponents of blood cell count, CA-125, age, body weight, height, and
diameter of lesions in the adnexa. The level of statistical signiﬁ-
cance was p < 0.05. In case of statistically signiﬁcant differences in
the levels of laboratory determinations (i.e., for ﬁbrinogen, CA-125
and leukocytes) the receiver operating curvewas speciﬁed. In these
cases, the area under the curve (AUC), sensitivity and speciﬁcity
were also analyzed. Cut-off points, characterized by the highest
sensitivity and speciﬁcity for individual parameters, were also
speciﬁed. Statistical calculations were made using STATISTICA
software by StatSoft.
Results
The age of the women in the study groups [endometriomas
(Group E) and mature teratomas (Group T)] was determined in a
statistically signiﬁcant manner (31 years vs. 26 years; p ¼ 0.002).
The age of the two study groups was crucial in the diagnosis of
endometriomas. If the diameter of the endometriomawas no larger
than 2 cm with no further clinical abnormalities then it was not
accepted for operative treatment. No statistically signiﬁcant dif-
ferences were shown for: the size of the lesions in the right ovary
and the left one; body weight; height; length of menstrual cycles
(28 days vs. 28 days; p ¼ 0.082); or the duration of menstruation (6
days vs. 5 days; p ¼ 0.021). The general characteristics of the
studied groups of women are presented in Table 1.
We determined the levels of urocortin, leptin, and ghrelin in
groups E and T (Table 2). The medians for these values were
105.31 pg/mL versus 120.84 pg/mL for urocortin, 7.16 pg/mL versus
9.13 pg/mL for leptin and 584.33 pg/mL versus 657.82 pg/mL for
ghrelin (p > 0.005). However, analysis of correlations with theSpearman test in the group of women with endometriomas
(Table 3) and the group of women treated surgically for mature
teratomas (Table 4) did not show any statistically signiﬁcant dif-
ferences for the tested parameters.
The blood cell counts were also analyzed. Statistically signiﬁcant
differences for the leukocyte levels (5.35  109/L vs. 6.7  109/L;
p ¼ 0.029) were shown in the respective groups. The level of he-
moglobin (8.02mM vs. 8.40mM), red blood cells (4.62  1012/L vs.
4.74  1012/L), hematocrit (38.9% vs. 39.7%) and blood platelets
(267.80  109/L vs. 258.90  109/L) did not show any statistically
signiﬁcant differences. Statistically signiﬁcant differences between
Groups E and T for ﬁbrinogen level (3.12 mg% vs. 2.57 mg%;
p ¼ 0.001) and CA-125 tumor marker (36.50 U/mL vs. 15.08 U/mL;
p ¼ 0.001) were found, as shown in Table 5.
Table 5
Comparison of leukocytes, ﬁbrinogen, and CA-125 serum level in patients with
endometriomas (Group E) and mature teratomas (Group T).
Determination Group Average SD Max. Min. Median p
Leukocytes (109/L) E 6.08 2.25 12.52 3.49 5.35 0.029*
T 6.63 1.63 11.2 4.32 6.7
Fibrinogen (mg%) E 3.26 0.45 3.98 2.60 3.12 0.001*
T 2.75 0.70 4.40 1.40 2.57
CA 125 (U/mL) E 49.69 33.77 171.90 8.71 36.50 0.001*
T 22.82 21.49 128.30 10.00 15.08
*p < 0.05 by ManneWhitney test.
SD ¼ standard deviation.
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Fig. 2. CA-125 value in prognostic diagnosis of lesions in the ovaries in the form of
endometriomas, with a suggested cut-off point of 25.24 U/mL (area under the
curve ¼ 0.818; 95% conﬁdence interval ¼ 0.722e0.915).
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ﬁbrinogen, CA-125 and leukocytes between the studied groups, the
values of cut-off points for individual parameters were also
analyzed. The role of the ﬁbrinogen value was proved in the
prognosis of lesions in the ovaries for the type of endometriomas,
with a suggested cut-off point of 2.85 mg% [AUC 0.755; 95% con-
ﬁdence interval (CI) ¼ 0.638e0.873]. The suggested cut-off point
for CA-125 was calculated as 25.24 U/mL (AUC 0.818; 95%
CI ¼ 0.722e0.915) and for leukocytes was 6.22  109/L (AUC 0.639;
95% CI ¼ 0.518e0.760). The receiver operating curve diagrams with
directional coefﬁcients and suggested cut-off points for ﬁbrinogen,
CA-125, and leukocytes are presented in Figs. 1, 2, and 3,
respectively.Specificity
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Fig. 3. Leukocyte value in prognostic diagnosis of lesions in the ovaries in the form of
endometriomas, with a suggested cut-off point of 6.22  109/L (area under the
curve ¼ 0.639; 95% conﬁdence interval ¼ 0.518e0.760).Discussion
Today, there is a signiﬁcant interest in plasma markers in
endometriosis for use in the diagnostics of endometriomas. This
study shows the role of blood tests measuring urocortin, ghrelin
and leptin levels in the diagnosis of endometriomas. Urocortin, is a
neuropeptide found both in the ovary and the endometrium;
however, it is not efﬁcient in the diagnostics of endometriosis le-
sions in the adnexa (endometriomas). Similar conclusions were
made in studies by Tokmak et al [5] and Florio et al [6].
Leptin, which belongs to the family of helical cytokines, regu-
lates the process of steroidogenesis in the gonads, ovulation, and
the decidual transformation of the endometrium. In the follicular
phase, the concentration of leptin in the blood is proportional to the
estradiol level [7,8]. Scientiﬁc reports on the leptin level in the
peritoneal ﬂuid in women with diagnosed endometriosis areROC diagram 
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Fig. 1. Fibrinogen value in prognostic diagnosis of lesions in ovaries in the form of
endometriomas, with a suggested cut-off point of 2.85 mg% (area under the
curve ¼ 0.755; 95% conﬁdence interval ¼ 0.638e0.873).divergent [9e13]. One could assume that the differences in endo-
metriosis and leptin levels depends on the stage of the disease. A
higher level of leptin in the peritoneal ﬂuid was observed in stages I
and II rather than in stages III and IV of endometriosis. Also, the
leptin/interleukin-8 ratio was lower in patients with ovarian
endometriosis than in peritoneal endometriosis [14]. Choi et al [15]
studied the level of expression of leptin and its receptor in endo-
metriomas and eutopic endometrium, which was 100% versus
59.5% for leptin and 72.7% versus 33.3% for its receptor.
Another group, Alviggi et al [16], studied leptin levels in the
peritoneal ﬂuid of women with superﬁcial lesions (i.e. on the sur-
face of ovaries) and deep lesions in endometriosis, compared to a
control group. The control group comprised female patients who
were treated for infertility of an unknown origin with neither
peritoneal nor ovarian endometriosis. The results indicated that the
leptin level was higher in those patients with endometriosis than in
the control group. However, the level of leptin was higher in the
peritoneal ﬂuid in the case of superﬁcial lesions. According to the
researchers, the leptin level may play a key role in the development
of superﬁcial endometriosis of the ovaries. One should, however,
consider whether superﬁcial and deep ovarian endometriosis has
other etiopathogenesis [16]. Our study showed that the average
concentration (median) of leptin in the blood serum of patients
K. Chmaj-Wierzchowska et al. / Taiwanese Journal of Obstetrics & Gynecology 54 (2015) 126e130 129with endometriomas was 8.06 (7.16) pg/mL and was slightly lower
than the ones obtained in the group with teratomas 9.82 (9.13) pg/
mL. However, this difference was not statistically signiﬁcant
(p ¼ 0.284).
We also measured ghrelin levels, whose average concentration
(median) in the blood serum of patients with endometriomas was
606.78 (584.33) pg/mL, whichwas comparable to the concentration
in the control group with teratomas: 627.42 (657.82) pg/mL for
p¼ 0.7153. Can ghrelin play a role in the etiology of endometriosis?
The expression of ghrelin and its receptor (growth hormone
secretagogue receptor) was found in the cells of ectopic endome-
trium in stages III and IV of endometriosis (endometriomas and
peritoneal endometriosis) [17]. An increased ghrelin level was
found in the peritoneal ﬂuid of patients with endometriosis and it
showed a positive correlation with peritoneal vascular endothelial
growth factor (r(s) ¼ 0.625) when compared to the control group
[18]. Studies on the role of ghrelin in the pathophysiology of
endometriosis and/or endometriomas are scarce in medical data-
bases. Thus, we cannot comment on our results compared to other
studies. However, our ﬁndings should encourage scientists to study
this matter further.
Despite the large number of potential biochemical markers, only
the CA-125 protein is commonly used in everyday clinical practice
for the diagnosis of endometriomas [4,19]. A higher concentration
of this protein may be the result of the similarity of the glandular
epithelium in the uterus to ovarian Müller cells. However, it needs
to be considered that increased level of CA-125 (normal range up to
35 U/mL) is not solely associated with endometriomas and deep,
inﬁltrating endometriosis [20]. Studies by Szubert et al [21] show
that the average level of CA-125 in the blood serum in the group
treated for endometriosis (stage IIeIV peritoneal endometriosis or
endometrial cysts, n ¼ 44) was 33.98 U/mL, where in the control
group (without endometriosis, n ¼ 15) the level was 9.3 U/mL. The
average level of CA-125 in the peritoneal ﬂuid was 1241.88 U/mL in
the control group, where in the endometriosis group it was
2640.23 U/mL (p < 0.05). Despite the fact that the CA-125 serum
level increased, it was still considered to be within the upper limit
of normal and it correlated with the stage of progression of endo-
metriosis (r ¼ 0.5993; p < 0.001). The CA-125 level of 11 U/mL
shows a diagnostic value in the diagnosis of endometriosis
(AUC ¼ 0.794; 95% CI ¼ 0.668e0.921; p ¼ 0.001) [21]. Comparing
the results of the average (median) of CA-125 from the blood serum
of patients with endometriomas and patients with teratomas,
respectively: 49.69 (36.50) to 22.82 (15.08) U/mL; p < 0.001, we
may formulate a hypothesis that the values from the upper limit of
normal for CA-125 do not exclude the possibility of endometriomas
with a cut-off point of 25.24 U/mL (AUC ¼ 0.818; 95%
CI ¼ 0.722e0.915). On the other hand, studies by Bal et al [22]
revealed a signiﬁcantly higher concentration of the CA-125 anti-
gen in advanced endometriosis [stage IIIeIV according to the
American Fertility Society (AFS)]. The average concentration of CA-
125 was 41.33 U/mL as compared to the initial form (stages IeII
according to AFS), where the average concentration was 64.79 U/
mL. The results of average serum concentration of CA-125,
depending on the stage of progression of endometriosis acc. to
the AFS guidelines, were: 7.23 U/mL in stage I; 52.70 U/mL in stage
II; 39.54 U/mL in stage III; and 85.59 U/mL in stage IV [22].
It needs to be emphasized that a statistically signiﬁcant corre-
lation was also observed for the level of leukocytes [6.08 (5.35) vs.
6.63 (6.7)  109/L; p ¼ 0.029, respectively] in the studied groups of
patients with endometriomas and teratomas. Because of the sta-
tistically signiﬁcant differences in these leukocyte levels, a cut-off
point of 6.22  109/L (AUC ¼ 0.639; 95% CI ¼ 0.518e0.760) could
be used for the prognosis of ovarian lesions in the type of
endometriomas.The average concentration and median values for ﬁbrinogen in
the group with cysts and the ones with teratomas was 3.26 (3.12)
versus 2.75 (2.57) mg%; p < 0.001, respectively. Thus, the statisti-
cally signiﬁcant differences between the studied groups, with a cut-
off point for 2.88 mg% (AUC ¼ 0.755; 95% CI ¼ 0.638e0.873) for the
determinations of endometriomas seem all the more interesting. In
conclusion, the levels of CA-125, leukocytes, and ﬁbrinogen, in
combinationwith an ultrasound evaluation of the pelvis may prove
a very useful tool for the diagnosis of lesions in the adnexa of the
form endometriomas [23].
Conclusions
In conclusion, the obtained prognostic values for CA-125, leu-
kocytes and ﬁbrinogenmay prove a very useful tool in the diagnosis
of lesions in the adnexa of the form endometriomas.
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